June 16, 2020
Genomic medicine startup Lucence and the Agency for Science, Technology and Research (A*STAR), Singapore’s national research agency and a statutory board under the Ministry of Trade and Industry, today announced study results indicating that the reagent used in Lucence’s SAFER Sample saliva collection kit inactivates SARS-CoV-2 within 45 seconds of sample collection.
The development of the SAFER...
May 19, 2020
Austin, Texas-based EverlyWell, a digital platform that lets consumers order lab tests online and view their results, has received an FDA Emergency Use Authorization (EUA) for a COVID-19 at-home diagnostic sample collection kit that can be used with multiple diagnostic lab tests.
Announced Friday by the FDA and Monday by the startup, the EverlyWell COVID-19 Test Home Collection Kit includes nasal...
Above photo: A SMART AMR IRG researcher optimizing prototype assay.
Credit: Singapore-MIT Alliance for Research and Technology (SMART)
May 19, 2020
Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, has received a grant from the National Medical Research Council (NMRC) COVID-19 Research fund for the acceleration of research and development of rapid paper-based serological and diagnostic tests for COVID-19.
WHY IT MATTERS
Although dozens of diagnostic tests, based on RNA or antibody detection,...
Credit: GenScript Biotech
May 15, 2020
Singapore’s Duke-NUS Medical School, GenScript Biotech and the Diagnostics Development Hub (DxD) at Singapore’s Agency for Science, Technology and Research (A*STAR) announced an exclusive agreement to co-develop and manufacture a unique serological coronavirus (COVID-19) detection system known as the surrogate virus neutralization test (sVNT) or cPass.
This first of its kind test allows rapid...
May 13, 2020
Less than a week after the first home-collected saliva test for COVID-19 was authorized by the FDA, at least two consumer-facing telehealth brands say they have cut deals to sell these test kits to the public.
The first is consumer telehealth company Hims & Hers, best known for its mail-order wellness and sexual health products for men and women.
While the well-funded startup has...
May 13, 2020
Estonian health tech innovator Viveo Health has made its telemedicine platform "Virtual Office for Doctors" free to doctors and medical professionals worldwide. The release comes in line with the increased demand for reliable remote consultation platforms to accommodate safe working during the COVID-19 pandemic.
The "Virtual Office" accommodates chat, phone and video functions and works both...
May 8, 2020
Just a few hours ago the FDA greenlighted the first home-collected saliva sample for COVID-19. Rutgers Clinical Genomics Laboratory, which already landed an EUA in mid-April for its test, can now expand its efforts to include test kits for home collection.
Patients do so using a specially designed collection device. This sample is then sent off to the Rutgers Clinical Genomics Laboratory in a...
May 8, 2020
SWISS ARMY TESTS TRACING APP
A COVID-19 contact tracing app is being trialed by 100 soldiers at the Chamblon army base near Lausanne, Switzerland. The Bluetooth-enabled app logs if users have spent more than 15 minutes within two metres of another user. Then, when one uploads a positive test result for COVID-19, the system and alerts users to the contact. In order to test its efficacy, the...
May 6, 2020
New York City-based home-lab-test startup LetsGetChecked said this morning that it has wrapped up an oversubscribed $71 million Series C round co-led by Illumina Ventures and HLM Venture Partners.
The raise also included new backers Deerfield, CommonFund Capital and Angeles Investments, while investors Transformation Capital, Optum Ventures and Qiming Venture Partners USA returned to further fuel...
May 4, 2020
Following numerous reports of underperforming COVID-19 antibody tests, the FDA has raised the bar for these products in a revision to its emergency testing policy.
As of today, commercial manufacturers that notify the agency of their intent to submit a test for Emergency Use Authorization are required to do so within 10 business days from the date of notification. Further, the FDA has recommended...